Clinical Trials Logo

Filter by:
NCT ID: NCT04051268 Completed - Safety Issues Clinical Trials

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Start date: March 2, 2020
Phase: Phase 3
Study type: Interventional

Phase III study, Randomized, observer blind, lot to lot consistency, non inferiority to PQed typhoid conjugate vaccine and Typhoid Vi polysaccharide vaccine.

NCT ID: NCT04046289 Completed - Obesity Clinical Trials

Effects of Probiotics and Calcium Supplementation on Growth, Development, and Metabolic Parameters

PROBIOCAL
Start date: January 26, 2019
Phase:
Study type: Observational

Stunting is still a major problem in developing countries, including Indonesia, and has been associated with impaired development. Stunted children have also a higher risk of metabolic syndrome in adulthood. The gut microbiota, as a part of intestinal integrity, may promote intake of nutrient during childhood. Probiotics supplementation may optimize the balance of gut microbiota and further improve child growth during the window period. Furthermore, calcium could also improve child growth by increasing the resistance to intestinal infection. However, the long-term effects of gut microbiota optimization during childhood using probiotics and calcium on growth, development, and the metabolic condition has not widely studied.

NCT ID: NCT04036825 Not yet recruiting - Malnutrition Clinical Trials

Liquid Nutritional Supplement on Malnutrition Hospitalized Patient

Start date: August 2019
Phase: N/A
Study type: Interventional

The aim of this study is to know the effectivity of liquid nutritional supplementation in malnutrition hospitalized patients

NCT ID: NCT04036240 Recruiting - Breast Feeding Clinical Trials

Finger Feeding as a Method of HMF Supplementation After Discharge

Start date: July 22, 2019
Phase: N/A
Study type: Interventional

Human Milk Fortifier (HMF) is designed to supply additional calories, protein, vitamins and minerals to infants less than 37 weeks gestation or those less than 1500 g at birth. Liquid and powder types of HMF are available in the commercial market. Usually, one packet of powdered HMF is mixed to 25-50 cc expressed breast milk. Fortification of human milk is technically difficult in fully breastfed infants and artificial teats such as bottle feedings are common used. A study reported lower breastfeeding rate in intervention group who used HMF in comparison with control. Finger feeding method is associated with a better breastfeeding rate in hospital use. A feasibility study in Vienna reports finger feeding method as a way to provide fortification at home was acceptable.We hypothesize that finger feeding is an easy way for HMF supplementation after discharge to increase successful breastfeeding and improve growth in preterm and or low birth weight infants.

NCT ID: NCT04029831 Completed - Analgesia Clinical Trials

Comparison of Different Ratio of Ketofol (6:1 vs. 4:1) for Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Study was aimed to compare the effect of ketofol between 6:1 and 4:1 ratio in patients who underwent ERCP

NCT ID: NCT04029662 Completed - Undefined Clinical Trials

Reducing Pain Intensity During Spinal Needle Insertion: Valsalva Maneuver vs. Control Technique

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

This study was aimed to observe the efficacy of Valsalva maneuver in reducing pain intensity during spinal needle insertion.

NCT ID: NCT04029649 Not yet recruiting - Ulcerative Colitis Clinical Trials

Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis

Start date: August 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to determine the efficacy and safety of Beta-1,3/1,6-D-Glucan from mycelium extract of Ganoderma lucidum on ulcerative colitis

NCT ID: NCT04023734 Completed - Hypertension Clinical Trials

A Targeted and Tailored Pharmacist Intervention to Improve Adherence to Antihypertensive Drugs Among Diabetes Patients

Start date: August 16, 2019
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the effect of a targeted and tailored pharmacist intervention on medication adherence among diabetes patients non-adherent to antihypertensive drugs. The secondary objectives are to assess the effect of the intervention on blood pressure level and medication beliefs, and to evaluate the implementation and adoption of the intervention for pharmacists and patients.

NCT ID: NCT04018131 Recruiting - Atopic Dermatitis Clinical Trials

The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy

Start date: March 26, 2018
Phase: Phase 3
Study type: Interventional

Extrinsic - atopic dermatitis is characterized by increased of IgE serum levels. Acute extrinsic - atopic dermatitis is a type 1 hypersensitivity that involve various inflammatory mediator including Interleukin-4, Interleukin-12, and Interferon-Ɣ. Recent treatment of atopic dermatitis mainly focused on reducing the inflammation through topical and systemic regiments. However, no systemic medication could control the atopic dermatitis remission yet, and the current immunosuppressive agent used may cause many side effects if administered on a long term basis. In the future, treatment of atopic dermatitis were specifically targeted to inhibit the role of Th2. Cimetidine is H2 receptor antihistamine that has been widely used as gastrointestinal medication for a long time. Cimetidine could modulate the immune system by activating the Th1 and lowering the Th2 activity, and lowering the IgE levels thus reducing the severity of atopic dermatitis.

NCT ID: NCT04014439 Completed - Clinical trials for Inflammatory Response

Relationship Between NLR and Prealbumin Levels With Diaphragm Thickness

Start date: September 1, 2019
Phase:
Study type: Observational [Patient Registry]

A study to find the relationship between neutrophil to lymphocyte ratio (NLR) with diaphragm thickness of critical patients in ICU.